City of Hope Scientists to Share New Findings on Cancer Risk, Immune Resistance and AI‑Driven Discovery at AACR 2026
This image was generated by AI and may not depict real events.
City of Hope researchers will present new findings on cancer risk, treatment resistance, and AI-driven discovery at the AACR Annual Meeting 2026. The presentations will cover various topics, including CAR T cell therapy and the role of the microbiome in cancer treatment.
City of Hope researchers will present 103 sessions at the AACR Annual Meeting 2026, sharing insights into cancer risk and treatment resistance. The presentations will cover topics such as CAR T cell therapy for acute lymphoblastic leukemia and the microbiome's role in cancer treatment outcomes. Researchers will also discuss how AI is being used to identify distinct microbiome patterns linked to early-onset colorectal cancer and improve predictions of immune targets for cancer vaccines. Additionally, new findings on a pathway that explains why many colorectal tumors resist immunotherapy will be presented. The meeting will take place from April 17-22.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.